FUSD:F:F-Fidelity UCITS SICAV - Fidelity US Quality Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.209

Change

0.00 (0.00)%

Market Cap

USD 0.81B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.27%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.14 (+0.27%)

USD 117.80B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.13 (+0.23%)

USD 92.18B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.72 (+0.14%)

USD 85.13B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.13 (+0.60%)

USD 75.40B
EUNL:F iShares Core MSCI World UCITS ..

+0.22 (+0.24%)

USD 72.04B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.21%)

USD 56.70B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.30 (+0.58%)

USD 55.70B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.15 (-0.17%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.46 (+0.50%)

USD 51.63B

ETFs Containing FUSD:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.02% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.02% 61% D- 58% F
Trailing 12 Months  
Capital Gain 19.78% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.78% 72% C 64% D
Trailing 5 Years  
Capital Gain 71.68% 81% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 71.68% 80% B- 63% D
Average Annual (5 Year Horizon)  
Capital Gain 10.60% 83% B 76% C+
Dividend Return 10.60% 82% B 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.19% 51% F 77% C+
Risk Adjusted Return 86.94% 95% A 94% A
Market Capitalization 0.81B 69% C- 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike